Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors
2022 · Nature Cancer · 72 citations
https://doi.org/10.1038/s43018-022-00393-y
O
Omid Hajihassani
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
315
Citations
9
h-index
9
i10-index
Omid Hajihassani is an academic researcher from University School. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Epigenetics and DNA Methylation & Histone Deacetylase Inhibitors Research. The author has an h-index of 9, co-authored 64 publications.
ORCID: 0000-0003-2871-5318Papers by this author
worksIncreased glucose availability sensitizes pancreatic cancer to chemotherapy
2023 · Nature Communications · 34 citations
https://doi.org/10.1038/s41467-023-38921-8
IDO1 Is a Therapeutic Target for Pancreatic Cancer–Associated Depression
2022 · Molecular Cancer Therapeutics · 16 citations
https://doi.org/10.1158/1535-7163.mct-22-0055
Data from IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.c.7451270.v1
Dataset1 from IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27024170
Dataset2 from IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27024167
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat